Skip to main content

Together we are beating cancer

Donate now

Latest News

Showing 12 out of 5857 results
A couple holding hands in a doctor's waiting room

Our latest analysis suggests there could be more than 900,000 cancer deaths in the UK by the end of the new government’s first parliamentary term if we don't take bold action. Our latest analysis suggests there could be more than 900,000 cancer deaths in the UK by the end of the new government’s first parliamentary term if we don't take bold action.

by Sophie Wedekind | Analysis | 9 September 2024

9 September 2024

Childhood cancer patient
  • For Researchers

Failing the most vulnerable

Meeting the needs of children and young people with cancer will mean facing the market’s failure to get new drugs to the clinic head-on says Sam Daems... Meeting the needs of children and young people with cancer will mean facing the market’s failure to get new drugs to the clinic head-on says Sam Daems...

by Cancer Research UK | Analysis | 6 September 2024

6 September 2024

Researcher at the Crick Skylab.

The Francis Crick Institute and MSD (tradename of Merck & Co., Inc., Rahway, N.J., USA (NYSE: MRK)), have opened a new Skylab facility, extending the footprint of the Crick and expanding opportunities for collaboration between the two organisations.  The Francis Crick Institute and MSD (tradename of Merck & Co., Inc., Rahway, N.J., USA (NYSE: MRK)), have opened a new Skylab facility, extending the footprint of the Crick and expanding opportunities for collaboration between the two organisations. 

by Krishna Sharma | 5 September 2024

5 September 2024

scientists in a lab

Cancer Research UK and LifeArc are investing £28m in funding and resources as part of a pioneering international initiative dedicated to developing new medicines exclusively for children’s and young people’s cancers. Cancer Research UK and LifeArc are investing £28m in funding and resources as part of a pioneering international initiative dedicated to developing new medicines exclusively for children’s and young people’s cancers.

by Sophie Wedekind | News | 5 September 2024

5 September 2024

Neural crest cells

After an absolute bumper crop of entries to our Research is Beautiful campaign – we have our August winner! After an absolute bumper crop of entries to our Research is Beautiful campaign – we have our August winner!

by Phil Prime | In depth | 4 September 2024

4 September 2024

This entry is part 6 of 6 in the series Research is Beautiful
Sânziana Foia in the lab with an image of Papcup, the new HPV test she has designed for cervical screening, on a laptop.

Sânziana Foia is developing a cervical screening device designed to detect high-risk HPV in menstrual blood within minutes. It could help remove some of the biggest barriers to cervical screening, helping many more eligible people take part.  Sânziana Foia is developing a cervical screening device designed to detect high-risk HPV in menstrual blood within minutes. It could help remove some of the biggest barriers to cervical screening, helping many more eligible people take part. 

by Sadaf Shafaghmotlagh | Analysis | 4 September 2024

4 September 2024

Abdullah, Aleesha-Marie and Faye, who all took part in clinical trials funded by Cancer Research UK

Clinical trials are how we bring better cancer treatments to children and young people. For Childhood Cancer Awareness Month, we asked parents what they're actually like. Clinical trials are how we bring better cancer treatments to children and young people. For Childhood Cancer Awareness Month, we asked parents what they're actually like.

by Tom Bourton, Tim Gunn | Personal stories | 3 September 2024

3 September 2024

Two cancer researchers looking at a cell image on screen

For Childhood Cancer Awareness Month, we're highlighting some our most important research into children's and young peoples' cancers over the past year. For Childhood Cancer Awareness Month, we're highlighting some our most important research into children's and young peoples' cancers over the past year.

by Momoko Bowles | Analysis | 1 September 2024

1 September 2024

A woman reading a cancer information limit while waiting to see the doctor.

Testing women with symptoms that could be linked to ovarian cancer is an effective way of finding aggressive forms of the disease in their early stages, according to research we helped fund. Testing women with symptoms that could be linked to ovarian cancer is an effective way of finding aggressive forms of the disease in their early stages, according to research we helped fund.

by Tim Gunn | News | 15 August 2024

15 August 2024

Research careers

We must ensure postdocs are well armed to take the next step to become a group leader but, says Ally Walters, we can’t neglect other career options… We must ensure postdocs are well armed to take the next step to become a group leader but, says Ally Walters, we can’t neglect other career options…

by Cancer Research UK | Analysis | 14 August 2024

14 August 2024

This entry is part 4 of 4 in the series Research Careers
A transparent microplate, made up of small test tubes, over a screen showing a DNA profile.

NHS England is changing the way that researchers access health data in England by moving to a network of Secure Data Environments. With proper government support, it can help researchers find better ways to prevent, diagnose and treat cancer. NHS England is changing the way that researchers access health data in England by moving to a network of Secure Data Environments. With proper government support, it can help researchers find better ways to prevent, diagnose and treat cancer.

by Ben Jones | In depth | 8 August 2024

8 August 2024